Dorothy JoAnn Wiley1, Hilary Hsu, Robert Bolan, Alen Voskanian, David Elashoff, Stephen Young, Ruvy Dayrit, Provaboti Barman, Katherine DeAzambuja, Emmanuel V Masongsong, Otoniel Martínez-Maza, Roger Detels. 1. 1Translational Science Section, School of Nursing, University of California at Los Angeles, Los Angeles; 2Los Angeles Gay and Lesbian Center, Jeffrey Goodman Clinic, Hollywood; 3Center for Clinical AIDS Research and Education (University of California at Los Angeles-CARE Center); 4Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles; and 5Jonsson Comprehensive Cancer Center, Los Angeles, CA; 6Tricore Diagnostic Laboratories, University of New Mexico, Albuquerque, NM; and 7University of California at Los Angeles AIDS Institute; and 8Department of Obstetrics and Gynecology, David Geffen School of Medicine, and 9Jonathan & Karin Fielding School of Public Health, University of California at Los Angeles, Los Angeles, CA.
Abstract
OBJECTIVES: Nylon-flocked and Dacron swab anal cytology collection procedures were evaluated for detecting high-grade anal intraepithelial neoplasia. MATERIALS AND METHODS: Cross-sectional data for 42 HIV-infected and 16 uninfected men who have sex with men have been used. Sequentially collected anal cytology specimens, high-resolution anoscopy, and medical biopsy evaluated the sensitivity and specificity of cytology for predicting high-grade anal intraepithelial neoplasia. Men showing atypical squamous cells (ASC) or more severe findings by cytology were compared with those showing negative for intraepithelial lesions. RESULTS: The prevalence of high-grade anal intraepithelial neoplasia was 35% (21/58), and findings were approximately 1.5 times higher among HIV-infected compared with uninfected men. Unsatisfactory cytology was twice as common among Dacron compared with nylon-flocked swab protocol specimens (14% [8/58] vs 7% [4/58]). Sensitivity and specificity for the nylon-flocked protocol cytology showing ASC or more severe findings were 81% (58%-95%) and 73% (50%-89%), respectively. Dacron protocol specimens showed 52% (30%-74%) and 58% (34%-80%) sensitivity and specificity, respectively. Men showing ASC or more severe findings using the nylon-flocked protocol cytology showed 3-fold higher odds for high-grade anal intraepithelial neoplasia compared with men with negative results (p < .05), but no statistically significantly higher odds of high-grade anal intraepithelial neoplasia for men showing ASC or more severe findings compared with those with negative results for Dacron protocol cytology (p > .05). CONCLUSIONS: The nylon-flocked protocol better detects high-grade anal intraepithelial neoplasia than does the Dacron protocol, yields more interpretable results, and classifies men with high-grade anal intraepithelial neoplasia as cytologically abnormal 2.5 times more often, even in this small clinical trial. CLINICAL TRIALS REGISTRATION NUMBER: NCT00955591.
OBJECTIVES:Nylon-flocked and Dacron swab anal cytology collection procedures were evaluated for detecting high-grade anal intraepithelial neoplasia. MATERIALS AND METHODS: Cross-sectional data for 42 HIV-infected and 16 uninfected men who have sex with men have been used. Sequentially collected anal cytology specimens, high-resolution anoscopy, and medical biopsy evaluated the sensitivity and specificity of cytology for predicting high-grade anal intraepithelial neoplasia. Men showing atypical squamous cells (ASC) or more severe findings by cytology were compared with those showing negative for intraepithelial lesions. RESULTS: The prevalence of high-grade anal intraepithelial neoplasia was 35% (21/58), and findings were approximately 1.5 times higher among HIV-infected compared with uninfected men. Unsatisfactory cytology was twice as common among Dacron compared with nylon-flocked swab protocol specimens (14% [8/58] vs 7% [4/58]). Sensitivity and specificity for the nylon-flocked protocol cytology showing ASC or more severe findings were 81% (58%-95%) and 73% (50%-89%), respectively. Dacron protocol specimens showed 52% (30%-74%) and 58% (34%-80%) sensitivity and specificity, respectively. Men showing ASC or more severe findings using the nylon-flocked protocol cytology showed 3-fold higher odds for high-grade anal intraepithelial neoplasia compared with men with negative results (p < .05), but no statistically significantly higher odds of high-grade anal intraepithelial neoplasia for men showing ASC or more severe findings compared with those with negative results for Dacron protocol cytology (p > .05). CONCLUSIONS: The nylon-flocked protocol better detects high-grade anal intraepithelial neoplasia than does the Dacron protocol, yields more interpretable results, and classifies men with high-grade anal intraepithelial neoplasia as cytologically abnormal 2.5 times more often, even in this small clinical trial. CLINICAL TRIALS REGISTRATION NUMBER: NCT00955591.
Authors: L Conley; T Bush; T M Darragh; J M Palefsky; E R Unger; P Patel; E M Kojic; S Cu-Uvin; H Martin; E T Overton; J Hammer; K Henry; C Vellozzi; K Wood; J T Brooks Journal: J Infect Dis Date: 2010-10-06 Impact factor: 5.226
Authors: Peter V Chin-Hong; Eric Vittinghoff; Ross D Cranston; Lynette Browne; Susan Buchbinder; Grant Colfax; Maria Da Costa; Teresa Darragh; Dana Jones Benet; Franklyn Judson; Beryl Koblin; Kenneth H Mayer; Joel M Palefsky Journal: J Natl Cancer Inst Date: 2005-06-15 Impact factor: 13.506
Authors: P A Fox; J E Seet; J Stebbing; N Francis; S E Barton; S Strauss; T G Allen-Mersh; B G Gazzard; M Bower Journal: Sex Transm Infect Date: 2005-04 Impact factor: 3.519
Authors: Anna-Barbara Moscicki; Teresa M Darragh; J Michael Berry-Lawhorn; Jennifer M Roberts; Michelle J Khan; Lori A Boardman; Elizabeth Chiao; Mark H Einstein; Stephen E Goldstone; Naomi Jay; Wendy M Likes; Elizabeth A Stier; Mark L Welton; Dorothy J Wiley; Joel M Palefsky Journal: J Low Genit Tract Dis Date: 2015-07 Impact factor: 1.925
Authors: G A Binda; G Gagliardi; I Dal Conte; M Verra; P Cassoni; E Cavazzoni; E Stocco; S Delmonte; P De Nardi; L Sticchi; M Mistrangelo Journal: Tech Coloproctol Date: 2019-06-26 Impact factor: 3.781
Authors: Dorothy J Wiley; Hilary K Hsu; Martha A Ganser; Jenny Brook; David A Elashoff; Matthew G Moran; Stephen A Young; Nancy E Joste; Ronald Mitsuyasu; Teresa M Darragh; David H Morris; Otoniel M Martínez-Maza; Roger Detels; Jian Yu Rao; Robert K Bolan; Eric T Shigeno; Ernesto Rodriguez Journal: Cancer Cytopathol Date: 2019-03-26 Impact factor: 5.284